Şunu aradınız:: ecog (İngilizce - Danca)

ecog ps=0
ecog-ps = 0

ecog=0 or 1
ecog=0 eller 1

ecog performance status, n (%)
ecog performance status n (%)

patients with high ecog performance status
patienter med høj ecog præstationsstatus

baseline ecog performance status (ps) = 0
ecog performance status (ps)= 0 ved baseline

analysis for os and pfs by ecog ps was also performed.
analyse for os og pfs blev også udført ved ecog ps.

all patients had a baseline ecog performance status of 0 or 1.
alle patienter havde en ecog-performancestatus ved baseline på 0 eller 1.

all patients included in this study had an ecog performance status 0 or 1.
alle patienter, der var inkluderet i dette studie havde en funktionsstatus for ecog på 0 eller 1.

only patients with ecog performance status 0 and 1 were enrolled in study go28141.
kun patienter med ecog-performancestatus 0 og 1 blev inkluderet i studie go28141.

patients randomised to maintenance treatment were required to have an ecog performance status 0 or 1.
de patienter, som blev randomiseret til vedligeholdelsesbehandling, skulle have en ecog performancestatus på 0 eller 1.

clinical trials excluded patients with ecog performance status > 1 and mucosal melanoma.
i kliniske forsøg blev patienter med ecog performance status >1 og mucosalt melanom ekskluderet.

population pharmacokinetic analyses of demographic data indicate that no dose adjustments are necessary for weight or ecog score.
populationsfarmakokinetiske analyser af demografiske data tyder på, at dosisjustering ikke er nødvendig med hensyn til vægt eller ecog score.

the ecog performance status was comparable between both groups, as was the number and type of prior therapies.
ecog-(eastern cooperative oncology group)-performance-status var næsten ens for begge grupper, hvilket også gjaldt for antallet og typen af tidligere behandlinger.

# a total of 154 patients (ecog performance status 0 or 1) were randomized.
# i alt blev 154 patienter (ecog-performancestatus 0 eller 1) randomiseret.

male patients comprised 57% of study population and 70% of patients were baseline ecog 0 performance status.
de mandlige patienter udgjorde 57% af studiepopulationen, og 70% af patienterne havde ecog performance status 0 ved baseline.

demographics and baseline disease characteristics were comparable between the nexavar and the placebo group with regard to ecog status (status 0:
demografi og baseline sygdomskarakteristika var sammenlignelige mellem nexavar - og placebogruppen med hensyn til ecog status (status 0:

over 99% of patients had an ecog (eastern cooperative oncology group) performance status of 0 or 1.
over 99 % af patienterne havde en ecog- (eastern cooperative oncology group) præstationsstatus på 0 eller 1.

baseline females baseline ecog performance status (ps) = 0 baseline ecog performance status (ps) = 1 baseline ecog performance status (ps) = 2 metastatic disease at baseline
baseline kvinder ecog performance status (ps) = 0 ved baseline ecog performance status (ps) = 1 ved baseline ecog performance status (ps) = 2 ved baseline metastserende sygdom ved baseline